NASDAQ · Financial Statements
Cerenome, Inc. (CNSY) Financial Statements
$1.93
NASDAQ: CNSY
Market Cap $13.28M
Overview Financials Dividend Cerenome, Inc. most recently reported annual revenue of $5.0M, net profit of $-22.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $5.0M $6.0M $5.0M Operating Profit $-12.0M $-20.0M $-13.0M $-15.0M $-15.0M Net Profit $-13.0M $-20.0M $-13.0M $-13.0M $-22.0M EPS $-444500.00 $-288750.00 $-106000.00 $-58.50 $-7.19 Op Margin — -8800.0% -271.1% -252.3% -293.5%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $22.0M $24.0M $11.0M $7.0M $16.0M Total Liabilities $11.0M $17.0M $13.0M $16.0M $12.0M Cash $18.0M $18.0M $9.0M $0 $9.0M Borrowings $7.0M $6.0M $4.0M $3.0M $1.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-10.0M $-13.0M $-13.0M $-11.0M $-21.0M Investing Cash Flow $0 $-2.0M $0 $-4.0M $-1.0M Financing Cash Flow $2.0M $-1.0M $0 $0 $19.0M Net Cash Flow $10.0M $0 $-10.0M $-8.0M $9.0M Free Cash Flow $-10.0M $-14.0M $-13.0M $-11.0M $-21.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.61 FCF Yield -147.15% Quick Ratio 1.37 Interest Coverage -8.56 Return 1Y -73.48% Return 3Y -94.11% Return 5Y -99.51%
Screens featuring this stock